Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
HTG Molecular Diagnostics, Inc. was a life science company focused on precision medicine. Their proprietary HTG EdgeSeq technology automated complex RNA and DNA analysis, primarily utilized in drug discovery, translational research, and molecular diagnostics. The company developed and marketed instruments, consumables, and software for molecular profiling. In July 2023, QuidelOrtho Corporation completed the acquisition of substantially all assets of HTG Molecular Diagnostics after HTG filed for Chapter 11 bankruptcy. HTG's operations as an independent entity have since ceased.
The Tucson headquarters served as the primary hub for research and development, manufacturing of its proprietary instruments and consumables, as well as corporate, administrative, and commercial operations.
The facility likely housed advanced molecular biology laboratories, clean rooms for reagent manufacturing, and engineering spaces for instrument development.
As a biotech company, the work culture likely emphasized innovation, scientific rigor, collaboration, and a focus on advancing precision medicine. It would have attracted individuals passionate about genomics and diagnostics.
The headquarters was central to the development and commercialization of HTG's core EdgeSeq technology, representing its innovation engine and operational backbone before its acquisition.
Prior to its acquisition, HTG Molecular Diagnostics supported a global customer base, particularly in North America, Europe, and parts of Asia-Pacific. This was achieved through direct sales efforts and a network of distributors. Their solutions were used by biopharmaceutical companies, academic institutions, and clinical research laboratories worldwide for drug development and diagnostic applications.
3430 E. Global Loop
Tucson
Arizona
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, HTG Molecular Diagnostics' leadership includes:
HTG Molecular Diagnostics has been backed by several prominent investors over the years, including:
The most significant executive changes at HTG Molecular Diagnostics occurred in conjunction with its acquisition by QuidelOrtho in mid-2023. This led to the departure of its leadership team as HTG's independent operations ceased. Information below reflects the period before and during the acquisition.
Discover the tools HTG Molecular Diagnostics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition, HTG Molecular Diagnostics likely used standard corporate email formats. Common formats include first initial followed by last name, or first name followed by last name, at their company domain.
[first_initial][last]@htgmolecular.com or [first].[last]@htgmolecular.com
Format
jdoe@htgmolecular.com
Example
0%
Success rate
QuidelOrtho Press Release / GlobeNewswire • July 19, 2023
QuidelOrtho Corporation announced it has completed its acquisition of substantially all of the assets of HTG Molecular Diagnostics, Inc. This acquisition followed HTG's Chapter 11 bankruptcy filing....more
GlobeNewswire / HTG Press Release • June 6, 2023
HTG Molecular Diagnostics, Inc. announced it had entered into an asset purchase agreement with QuidelOrtho and that HTG and its U.S. subsidiaries initiated voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code to facilitate the sale....more
HTG Molecular Diagnostics Press Release • May 15, 2023
HTG Molecular Diagnostics reported its financial results for the first quarter ended March 31, 2023, highlighting revenue and operational updates prior to its bankruptcy filing and acquisition....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including HTG Molecular Diagnostics, are just a search away.